Scott M. Coiante
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Scott M. Coiante
Scott M. Coiante is recorded as CFO at Lexicon Pharmaceuticals, Inc. (LXRX). Lexicon Pharmaceuticals, Inc. reported in an 8-K filed January 2, 2025 that Scott M. Coiante was appointed senior vice president and chief financial officer, effective January 2, 2025. Scott M. Coiante has spoken on 5 earnings calls across 1 company, most recently for Lexicon Pharmaceuticals, Inc. on August 6, 2026.
“Effective as of January 2, 2025, Scott M. Coiante was appointed as our senior vice president and chief financial officer, in which capacity he will function as our principal financial officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexicon Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Michael Exton, Ph.D. CEO, Board Member
- Michael S. Exton CEO, Board Member
- Raymond Debbane Chairman
- Kristen L. Alexander CFO, Chief Accounting Officer
- Jeffrey L. Wade COO
- Christopher J. Sobecki Board Member
- Diane E. Sullivan Board Member
- Ivan H. Cheung Board Member
- Judith L. Swain Board Member
- Philippe J. Amouyal Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.